These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33137158)

  • 1. Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study.
    Takada K; Takamori S; Matsubara T; Haratake N; Akamine T; Kinoshita F; Ono Y; Wakasu S; Tanaka K; Oku Y; Oba T; Osoegawa A; Tagawa T; Takenoyama M; Shimokawa M; Oda Y; Mori M
    PLoS One; 2020; 15(11):e0241580. PubMed ID: 33137158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer.
    Shoji F; Kozuma Y; Toyokawa G; Yamazaki K; Takeo S
    Ann Thorac Cardiovasc Surg; 2020 Oct; 26(5):248-255. PubMed ID: 32074540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
    Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
    Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer.
    Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY
    Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
    Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
    Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of various hematological variables as markers of systemic inflammation in metastatic lung cancer.
    Bayir D; Seber S; Yetisyigit T
    J Cancer Res Ther; 2020; 16(4):731-736. PubMed ID: 32930111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer.
    Zhang F; Ying L; Jin J; Chen K; Zhang N; Wu J; Zhang Y; Su D
    Oncotarget; 2017 Jan; 8(5):8835-8842. PubMed ID: 27823974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: A retrospective study.
    Wang Y; Hu X; Xu W; Wang H; Huang Y; Che G
    Thorac Cancer; 2019 Jun; 10(6):1402-1411. PubMed ID: 31104359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non-Small-cell Lung Cancer Treated With Immunotherapy.
    Prelaj A; Rebuzzi SE; Pizzutilo P; Bilancia M; Montrone M; Pesola F; Longo V; Del Bene G; Lapadula V; Cassano F; Petrillo P; Bafunno D; Varesano N; Lamorgese V; Mastrandrea A; Ricci D; Catino A; Galetta D
    Clin Lung Cancer; 2020 Jul; 21(4):365-377.e5. PubMed ID: 32245624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs.
    Zhang Y; Feng YC; Zhu HG; Xiong TC; Hou YS; Song J; Jiang W; Zhu CJ
    Medicine (Baltimore); 2018 Jul; 97(30):e11648. PubMed ID: 30045314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Non-Small-Cell Lung Cancer.
    Guo M; Sun T; Zhao Z; Ming L
    Ann Thorac Cardiovasc Surg; 2021 Apr; 27(2):84-90. PubMed ID: 33162436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients With Stage I Non-Small Cell Lung Cancer Undergoing Complete Resection.
    Xia H; Sun Z; Deng L; Zhu D; Wang D
    Cancer Invest; 2016 Sep; 34(8):378-84. PubMed ID: 27558529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
    J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
    BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
    Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
    Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Shaverdian N; Veruttipong D; Wang J; Schaue D; Kupelian P; Lee P
    Clin Lung Cancer; 2016 Jan; 17(1):39-46. PubMed ID: 26372098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.